US EditionPublished • loading... • Updated
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit ...
- Purchasers or sellers of Cepton, Inc. common stock between July 29, 2024, and January 6, 2025, are reminded of the December 8, 2025, lead plaintiff deadline as stated by Rosen Law Firm.
- Individuals who bought or sold Cepton, Inc. stock during the Class Period may be eligible for compensation without upfront fees or costs.
- A lead plaintiff represents other class members in directing litigation and must file a motion by December 8, 2025.
- The lawsuit claims that defendants made materially false and misleading statements about Cepton's business and operations throughout the Class Period.
Insights by Ground AI
52 Articles
52 Articles
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit ...
LOS ANGELES, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK ) for violations of §§10(b) and…
Coverage Details
Total News Sources52
Leaning Left6Leaning Right4Center17Last UpdatedBias Distribution63% Center
Bias Distribution
- 63% of the sources are Center
63% Center
L 22%
C 63%
15%
Factuality
To view factuality data please Upgrade to Premium
